Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NeoGenomics (NASDAQ:NEO – Get Rating) had its price target lifted by equities research analysts at Piper Sandler from $20.00 to $23.00 in a research report issued to clients and investors on Monday, The Fly reports. Piper Sandler’s target price suggests a potential upside of 18.86% from the stock’s previous close. NEO has been the topic […]
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 7,080,000 shares, an increase of 12.7% from the April 15th total of 6,280,000 shares. Based on an average daily volume of 1,250,000 shares, the short-interest […]
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 7,080,000 shares, an increase of 12.7% from the April 15th total of 6,280,000 shares. Based on an average trading volume of 1,250,000 shares, the short-interest ratio is currently […]
/PRNewswire/ -- The pharmaceutical contract manufacturing market size is set to grow by USD 58 billion from 2022 to 2027 progressing at a CAGR of 7.81% during...
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) reached a new 52-week high on Wednesday . The stock traded as high as $19.65 and last traded at $19.44, with a volume of 767276 shares. The stock had previously closed at $18.25. Analysts Set New Price Targets Several analysts have recently weighed in on NEO shares. Raymond James […]